Skip to main content
. 2013 Oct 30;5(8):2052–2064. doi: 10.18632/oncotarget.1504

Table II. Patients' cytogenetics.

# of pts IDO-positive IDO-negative
Normal karyotype 13 3 10*
FLT3-ITD 8 5 3
inv(16) 5 5 0
MLL rearrangement 5 5 0
t(8;21) 5 1 4
*

p=0.0065 compared with children harboring inv(16) or MLL rearrangement.